Holman, Mark

Expanesthetics is a pioneering company in inhaled general anesthetic drug development, dedicated to expanding access to surgical procedures for the 5 billion people worldwide who lack timely surgical care due to the complexities and costs associated with current anesthetic options. With a strong scientific foundation and a leadership team comprising experienced professionals and clinical experts, Expanesthetics aims to drive meaningful advancements in the field while generating sustainable returns for its investors.

Under the guidance of Dr. Robert Brosnan and a team of over 100 invested anesthesiologists, Expanesthetics is focused on innovating new inhaled anesthetics that promise fewer side effects and enhanced benefits, marking a significant move forward from the stagnation experienced in the industry over the past fifty years. The company's mission is to collaborate with other innovators to usher in a new era of anesthesia, ultimately transforming surgical access and improving patient outcomes globally.

Generated from the website